![Esmé c. Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Esmé c. Smith
Nessuna posizione attualmente
Profilo
Esmé c.
Smith is currently a Partner at Jones Day LP.
Previously, she worked as Secretary, Vice President & General Counsel at Heron Therapeutics, Inc. and as Vice President at Dendreon Corp.
from 2009 to 2012.
She received her undergraduate degree from the University of California, Santa Barbara and her graduate degree from Loyola Law School.
Precedenti posizioni note di Esmé c. Smith
Società | Posizione | Fine |
---|---|---|
DENDREON CORPORATION | Corporate Officer/Principal | 01/03/2012 |
HERON THERAPEUTICS, INC. | Consigliere Generale | - |
Formazione di Esmé c. Smith
University of California, Santa Barbara | Undergraduate Degree |
Loyola Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HERON THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Dendreon Corp.
![]() Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Esmé c. Smith